State of Michigan Retirement System’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Other funds holding DNLI
CM
GGHC
FP
State of Michigan Retirement System's DNLI Position: Q1 2021 in Review
State of Michigan Retirement System sold out of Denali Therapeutics (DNLI) in Q1 2021, closing a stake of 324,028 shares — an estimated $27.1M sold.
State of Michigan Retirement System first reported a position in DNLI in Q3 2020 and held it in 2 quarters. The position peaked at $27.1M in Q4 2020. 216 funds tracked by Wall St. Rank hold DNLI as of Q1 2021.
- State of Michigan Retirement System reported no remaining Denali Therapeutics position as of Q1 2021 after selling out during the quarter.
- State of Michigan Retirement System sold 324,028 Denali Therapeutics shares in Q1 2021, an estimated $27.1M.
- State of Michigan Retirement System first reported a position in Denali Therapeutics in Q3 2020 and held it in 2 quarters.
- State of Michigan Retirement System's Denali Therapeutics position peaked at $27.1M in Q4 2020.
- 216 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2021.
Based on State of Michigan Retirement System's 13F filing for Q1 2021, filed 3 May 2021.